Tuberculosis treatment success rate (% of new cases) in Europe & Central Asia
Europe & Central Asia: Tuberculosis treatment success rate (% of new cases) was 74.0% in 2023. ▬ Flat
Tuberculosis treatment success rate in Europe & Central Asia, 2000–2023
Source: Global Tuberculosis Report, World Health Organization (WHO). Measured in % of new cases.
Analysis
In 2023, tuberculosis treatment success rate in Europe & Central Asia stood at 74.0%.
That represents a change of down 1.3% on the previous year and down 2.6% over ten years.
Over the whole period, tuberculosis treatment success rate in Europe & Central Asia peaked at 77.0% in 2005 and was at its lowest, 72.0%, in 2020.
Tuberculosis treatment success rate (% of new cases) in Europe & Central Asia, year by year
| Year | % of new cases | Change |
|---|---|---|
| 2000 | 75.0% | — |
| 2001 | 73.0% | -2.7% |
| 2002 | 74.0% | +1.4% |
| 2003 | 74.0% | +0.0% |
| 2004 | 76.0% | +2.7% |
| 2005 | 77.0% | +1.3% |
| 2006 | 75.0% | -2.6% |
| 2007 | 76.0% | +1.3% |
| 2008 | 76.0% | +0.0% |
| 2009 | 75.0% | -1.3% |
| 2010 | 74.0% | -1.3% |
| 2011 | 73.0% | -1.4% |
| 2012 | 76.0% | +4.1% |
| 2013 | 76.0% | +0.0% |
| 2014 | 76.0% | +0.0% |
| 2015 | 77.0% | +1.3% |
| 2016 | 77.0% | +0.0% |
| 2017 | 76.0% | -1.3% |
| 2018 | 75.0% | -1.3% |
| 2019 | 75.0% | +0.0% |
| 2020 | 72.0% | -4.0% |
| 2021 | 72.0% | +0.0% |
| 2022 | 75.0% | +4.2% |
| 2023 | 74.0% | -1.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 75.1% | 73.0% | 77.0% | 10 |
| 2010s | 75.5% | 73.0% | 77.0% | 10 |
| 2020s | 73.2% | 72.0% | 75.0% | 4 |
Countries ranked near Europe & Central Asia
More health data for Europe & Central Asia
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, annual growth rate 0.621 % change on previous year (2025)
- Population ages 45-49, female, annual growth rate 0.9265 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0351 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 0.3995 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
- Population ages 10-14, male, annual growth rate 0.6344 % change on previous year (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is tuberculosis treatment success rate in Europe & Central Asia?
- Tuberculosis treatment success rate in Europe & Central Asia was 74.0% in 2023, according to Global Tuberculosis Report, World Health Organization (WHO).
- What is the highest tuberculosis treatment success rate recorded in Europe & Central Asia?
- The highest recorded value was 77.0% in 2005.
- What is the lowest tuberculosis treatment success rate recorded in Europe & Central Asia?
- The lowest recorded value was 72.0% in 2020.
- How does Europe & Central Asia rank for tuberculosis treatment success rate?
- Europe & Central Asia ranks 16th out of 19 groups with data for 2023.
- Is tuberculosis treatment success rate rising or falling in Europe & Central Asia?
- Over the last ten years it is down 2.6%. The long-run trend across the full record is flat.
- Where does this Europe & Central Asia data come from?
- The figures come from Global Tuberculosis Report, World Health Organization (WHO), published as part of Tuberculosis treatment success rate (% of new cases). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).